Trial Profile
Dose-Escalating Study to Evaluate MEDI-534 in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jul 2007
Price :
$35
*
At a glance
- Drugs MEDI 534 (Primary)
- Indications Parainfluenza virus infections; Respiratory syncytial virus infections
- Focus Adverse reactions
- 02 Jul 2007 Status changed from recruiting to completed
- 19 Oct 2005 New trial record.